Gambaran Klinis dan Histopatologi Kanker Ovarium di RSUP Dr. Hasan Sadikin Bandung Tahun 2019-2020

Salfa Aqilla,(1*) Ali Budi Harsono,(2) Hasrayati Agustina,(3)

(1) Universitas Padjadjaran
(2) Departemen Obstetri dan Ginekologi Fakultas Kedokteran Universitas Padjadjaran/ RSUP Dr. Hasan Sadikin Bandung
(3) Departemen Patologi Anatomi Fakultas Kedokteran Universitas Padjadjaran/ RSUP Dr. Hasan Sadikin Bandung
(*) Corresponding Author

Abstract


Tujuan: Penelitian ini bertujuan untuk mengetahui gambaran klinis dan histopatologi pasien kanker ovarium di RSHS tahun 2019-2020.
Metode: Penelitian deskriptif ini dilaksanakan di RSUP Dr. Hasan Sadikin Bandung dengan menggunakan data rekam medis pasien kanker ovarium yang didiagnosis secara histopatologi tahun 2019-2020. Sampel dipilih menggunakan metode total sampling.
Hasil: Penelitian ini menunjukan dari 140 pasien, mayoritas berusia 46-55 tahun (31,4%), multipara (60,7%), dan IMT normal (57,1%). Pasien mayoritas mengeluhkan adanya benjolan pada abdomen (100%) dengan karakteristik kistik sebagian padat (51,4%), berbenjol (57,1%), unilateral (87,4%), dan immobile (35,0%). Kebanyakan pasien memiliki nilai haemoglobin (75,3%) dan albumin (20,7%) rendah. Tumor marker yang paling sering ditemukan adalah CA 125 (37,9%). Mayoritas pasien didiagnosis pada stadium III (47,1%), tipe histopatologi mucinous carcinoma (20,0%) dan dilakukan operasi complete surgical staging (46,8%).
Kesimpulan: Pasien kanker ovarium tahun 2019-2020 terbanyak adalah pada usia 46-55, multipara, IMT normal, mengeluhkan massa pada abdomen dengan karakteristik kistik sebagian padat, berbenjol, unilateral. Umumnya pasien mengalami penurunan nilai haemoglobin dan albumin serta berada pada stadium III dengan tipe histopatologi mucinous carcinoma dan dilakukan operasi complete surgical staging.

Clinical Features and Histopathology of Ovarian Cancer at RSUP Dr. Hasan Sadikin Bandung 2019-2020

Abstract
Objective: This study aimed to determine the clinical and histopathological features of ovarian cancer patients at Hasan Sadikin General Hospital Bandung 2019-2020.
Method: This descriptive research was conducted at Hasan Sadikin General Hospital Bandung using medical record data for ovarian cancer patients diagnosed histopathologically in 2019-2020. The sample was selected using the total sampling method.
Results: This study showed that from 140 patients, the majority were aged 46-55 years (31.4%), multiparous (60.7%), and normal BMI (57.1%). The majority of patients complained of a lump in the abdomen (100%) with the characteristics of a cyst with partially solid (51.4%), uneven surface (57.1%), unilateral (87.4%), and immobile (35.0%). Most patients had low hemoglobin (75.3%) and albumin (20.7%) values. The most common tumor marker found was CA 125 (37.9%). The majority of patients were in stage III (47.1%), the histopathological type of mucinous carcinoma (20.0%), and underwent complete surgical staging (46.8%).
Conclusion: Most ovarian cancer patients in 2019-2020 were aged 46-55, multiparous, normal BMI, complained of a mass in the abdomen with the characteristics of a cyst with partially solid,uneven surface, unilateral. Generally, patients have decreased hemoglobin and albumin values were diagnosed as stage III, the histopathological type of mucinous carcinoma and underwent complete surgical staging.

Key words: ovarian cancer, clinical features, histopathology


Keywords


kanker ovarium, gambaran klinis, histopatologi

Full Text:

PDF

References


Ferlay J, Bray F, Colombet M, Mery L, Piñeros M, Znaor A, et al. Ovary. Global Cancer Observatory: Cancer Today: International Agency for Research on Cancer (IARC). 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/25-Ovary-fact-sheet.pdf

Ferlay J, Bray F, Colombet M, Mery L, Piñeros M, Znaor A, et al. Indonesia. Global Cancer Observatory: Cancer Today: International Agency for Research on Cancer (IARC). 2020. Available from: https://gco.iarc.fr/today/data/factsheets/populations/360-indonesia-fact-sheets.pdf

Smith RP, Netter FH. Netter’s obstetrics and gynecology. 3rd ed. Philadelphia, PA : Elsevier; 2016.

Bain CM, Burton K, Mcgavigan C. Gynaecology Ilustrated. 6th ed. Edinburg: Elsevier; 2011.

Herrington C. Muir’s textbook of pathology. 15th ed. Boca Raton: CRC Press/Taylor & Francis Group; 2014.

O’Dowd G, Bell S, Wright S. Wheater’s Basic Pathology: A Text, Atlas, and Review of Histopathology. 6th ed. Edinburg: Elsevier; 2019.

Nyoman Gede Budiana I, Kadek Aditya Prayudi P, Yudi Saspriyana K, Made Darmayasa I, Agung Gede Putra Wiradnyana A, Suwiyoga K. Characteristics of ovarian malignancy in Bali province, Indonesia. Med J Malaysia. 2021 Mar;76(3):326–31.

Noela F, Nuryanto KH. Epidemiology Data of Ovarian Cancer in Dr. Cipto Mangunkusumo Hospital, Jakarta. Indones J Obstet Gynecol. 2016;101–6.

Dhitayoni I, Budiana I. Profil pasien kanker ovarium di Rumah Sakit Umum Pusat Sanglah Denpasar-Bali Periode Juli 2013-Juni 2014. E-jurnal Med. 2017;6(3):1–9.

Kim SI, Song M, Hwangbo S, Lee S, Cho U, Kim JH, et al. evelopment of Web-Based Nomograms to Predict Treatment Response and Prognosis of Epithelial Ovarian Cancer. Cancer Res Treat. 2019;51(3):1144.

Yamada Y, Mabuchi S, Kawahara N, Kawaguchi R. Prognostic significance of tumor laterality in advanced ovarian cancer. Obstet Gynecol Sci. 2021;64(6):524–31.

Yazdani S, Javadian M, Bouzari Z, Ranaei M, Hajian-Taliki K, Ghafari A. The Predictive Role of Preoperative Leukocytosis, Anemia and Thrombocytosis with the Severity of Epithelial Ovarian Tumors. J Babol Univ Med Sci. 2018;20(12):21–7.

Chen Y, Zhang L, Liu WX, Liu XY. Prognostic Significance of Preoperative Anemia, Leukocytosis and Thrombocytosis in Chinese Women with Epithelial Ovarian Cancer. Asian Pacific J Cancer Prev. 2015;16(3):933–9.

Ayhan A, Günakan E, Alyazıcı İ, Haberal N, Altundağ Ö, Dursun P. The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet 2017. 2017;296(5):989–95.

Lynam S, Lele S. Role of Tumor Markers. In: Preventive Oncology for the Gynecologist. Springer, Singapore; 2019. p. 233–44.

Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S, et al. Ovarian cancer: Current status and strategies for improving therapeutic outcomes. Cancer Med. 2019;8(16):7018–31.

Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD, et al. Ovarian cancer statistics, 2018. CA Cancer J Clin. 2018;68(4):284–96.

Yulianti A. Gambaran Penyakit Kanker Ovarium Di Rumah Sakit Hasan Sadikin Bandung Periode Januari 2011 - Desember 2011” [Thesis]. Bandung: Untiversitas Kristen Maranatha; 2012.

Kurman RJ, Carcangiu ML, Herrington CS, Young RH. WHO classification of tumours of female reproductive organs. IARC. Lyon; 2014.

Dwilwstari A. Karakteriktik Penderita Kanker Ovarium di RS Wahidin Sudirohusodo Makassar Periode 1 Januari 2015 -31 Desember 2016 [Thesis]. Makassar: Untiversitas Hasanuddin; 2017

Trimbos JB. Surgical treatment of early-stage ovarian cancer. Best Pract Res Clin Obstet Gynaecol. 2017 May 1;41:60–70.




DOI: http://dx.doi.org/10.24198/obgynia/v5n1.363

Refbacks

  • There are currently no refbacks.





     
       

Creative Commons License
Indonesian Journal of Obstetrics & Gynecology Science is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License
  Web Analytics
  View My Stat